These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 12626034)

  • 21. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.
    Col NF; Chlebowski RT
    Menopause; 2008; 15(4 Suppl):804-9. PubMed ID: 18596602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
    Trinh XB; Peeters F; Tjalma WA
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):250-3. PubMed ID: 16144734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy: dilemmas in 2002.
    Moore A
    Trans Am Clin Climatol Assoc; 2003; 114():233-8; discussion 238-40. PubMed ID: 12813923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function.
    Huang KE; Xu L; I NN; Jaisamrarn U
    Maturitas; 2010 Mar; 65(3):276-83. PubMed ID: 20018469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal hormone therapy: have HERS2 and WHI given us any new information?
    Fylstra DL
    J S C Med Assoc; 2002 Dec; 98(8):299-304. PubMed ID: 12532655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progestins and recurrence in breast cancer survivors.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
    [No Abstract]   [Full Text] [Related]  

  • 28. Treating hot flashes in breast cancer survivors: a review of alternative treatments to hormone replacement therapy.
    Graf MC; Geller PA
    Clin J Oncol Nurs; 2003; 7(6):637-40. PubMed ID: 14705478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
    Mortimer JE
    Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The need for tissue selective menopausal agents.
    Eden J
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy in women with past history of endometriosis.
    Soliman NF; Hillard TC
    Climacteric; 2006 Oct; 9(5):325-35. PubMed ID: 17000581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmenopausal hormone therapy before and after breast cancer: clinical experiences.
    Bundred NJ; Turner LE
    Maturitas; 2004 Sep; 49(1):S22-31. PubMed ID: 15351104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.
    Gupta P; Sturdee DW; Palin SL; Majumder K; Fear R; Marshall T; Paterson I
    Climacteric; 2006 Feb; 9(1):49-58. PubMed ID: 16428125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case in point. Counseling about hormone replacement therapy.
    Mahon SM
    Oncol Nurs Forum; 1998 May; 25(4):663-4. PubMed ID: 9599344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tibolone: a unique version of hormone replacement therapy.
    Swegle JM; Kelly MW
    Ann Pharmacother; 2004 May; 38(5):874-81. PubMed ID: 15026563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of menopausal symptoms in women with breast cancer.
    Jubelirer SJ
    W V Med J; 1995 Feb; 91(2):54-6. PubMed ID: 7610643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
    Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current issues in hormone replacement therapy.
    Timins JK
    N J Med; 2004 Mar; 101(3):21-7. PubMed ID: 15042800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma.
    Diamanti-Kandarakis E; Sykiotis GP; Papavassiliou AG
    Cancer; 2003 Jan; 97(1):12-20. PubMed ID: 12491500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.